Predicting prostate biopsy results using a panel of plasma and urine biomarkers combined in a scoring system
Literature
Read More
NeoGenomics Schedules its Q4 2015 and Full Year 2015 Earnings Release for March 1, 2016
Press Release
Read More
Evidence of BRAF V600E in indeterminate cell tumor and interdigitating dendritic cell sarcoma
Literature
Read More
Positive selection and high sensitivity test for MYD88 mutations using locked nucleic acid
Literature
Read More
Chimerism analysis of cell-free DNA in patients treated with hematopoietic stem cell transplantation may predict early relapse in patients with hematologic malignancies
Literature
Read More
High sensitivity testing shows multiclonal mutations in patients with CLL treated with BTK inhibitor and lack of mutations in ibrutinib-naïve patients
Literature
Read More
NeoGenomics Launches New Liquid Biopsy Tests for Monitoring Solid Tumors and Predicting Resistance to BTK Inhibitors
Press Release
Read More